Abstract
Background: Both ABO and Rh blood group systems was correlated with a number of illnesses.
Aim: To estimate the occurrence of various types of leukemia with the ABO blood groups and Rh factor. The response of treatment relationship with ABO blood groups.
Patients and methods: This was a retrospective cohort study including A total of 200 cases diagnosed with leukemias according to the International Working Group (IWG) diagnostic criteria attending the hematology department of Harmel army hospital.
Results: 179 of 200 leukemic patients had acute leukemia (89.5%) and 31 (9.5%) patients had chronic leukemia,112 (62.6%) of acute leukemic patients were diagnosed with AML, while ALL represents 67 (37.4). The study reveals that in groups A+ ve AML patients, non-responding patients are more likely to be females, while in groups B+ ve AML patients, responding patients are more likely to be males. In groups O+ ve AML patients, non-responding patients are more likely to be males, while in group O-ve AML patients, non-responding patients are more likely to be males. males are more likely to respond to treatment in groups A+ ve All pt, B+ ve ALL pt, AB+ve ALL pt, and O+ve ALL pt, with no patients detected with blood groups AB-ve and O-ve. The response rate was higher in males than females.
Conclusion: Acute leukemia, particularly AML, is prevalent in adults, and ABO and RH can be used to predict leukemia types and treatment response.
Article Type
Original Article
Keywords
Leukemias; ABO; RH
How to Cite This Article
El Sayed, Zeinab Helmy; Qotb, Seham Sabry; Mostafa, Haytham Mohmmed; and Hussein, Asmaa Abu Bakr
(2024)
"Leukemias and its Treatment Response in Relation to the ABO Blood Group and Rh Factor,"
Al-Azhar International Medical Journal: Vol. 5:
Iss.
12, Article 29.
DOI: https://doi.org/10.58675/2682-339X.2808
